OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

NCT05096754 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2023-12-08

No results posted yet for this study

Summary

Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT CAP.

Conditions

  • Liver Transplant

Interventions

DEVICE

OCS Liver

Transplant with an OCS preserved liver.

Sponsors & Collaborators

  • TransMedics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2023-02-02
Completion
2023-02-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05096754 on ClinicalTrials.gov